Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents August 08, 2022; Volume Issue supplement 2

PhysicianPharm_Oral

      • Basic and Translational Neurosciences
      • Basic Science
      • Clinical Neurosciences (including neuro-oncology)
      • Clinical Science
      • Data Analysis & Management
      • Data Sciences
      • Dosimetry & Image Analysis
      • Early Phase (Phase 0 or I) human studies
      • Endocrine/Neuroendocrine Cancers
      • Gastroenterology
      • GI
      • GU
      • GYN
      • Head and Neck
      • Hematologic Malignancies
      • Image Generation
      • In vitro and In vivo Oncology
      • Infection and Inflammation in Probe Development
      • Infectious and Inflammatory Disease/Hematology/Musculoskeletal
      • Instrumentation
      • Non-oncology Endocrinology/Neuroendocrine
      • Novel Multimodality & Nonradioactive Probes
      • Novel Radiochemistry & Chelation
      • Other Solid Tumors
      • Outcomes/Comparative Effectiveness Research & Radiation Safety
      • Pediatrics
      • Preclinical Probes for Neuroimaging
      • Preclinical Probes for Oncology
      • Probes for Cardiovascular, Endocrine and Other - Preclinical
      • Pulmonary
      • Radiopharmacy & Clinical Production
      • Renal/Hypertension
      • Sarcoma/Melanoma
      • Technical Advances & Quantification (this would include image-guided diagnostics/therapy)
      • Thoracic (Lung/Pleura)

PhysicianPharm_Poster

      • Automation & Technology Development
      • Basic and Translational Neurosciences
      • Basic Science
      • Cardiovascular Sciences
      • Clinical Neurosciences (including neuro-oncology)
      • Clinical Science
      • Correlative Imaging (including instrumentation, image fusion and data analysis)
      • Data Analysis & Management
      • Data Sciences
      • Dosimetry & Image Analysis
      • Early Phase (Phase 0 or I) human studies
      • Endocrine/Neuroendocrine Cancers
      • Gastroenterology
      • General Clinical Specialties
      • GI
      • GU
      • GYN
      • Head and Neck
      • Hematologic Malignancies
      • Image Generation
      • In vitro and In vivo Oncology
      • Infection and Inflammation in Probe Development
      • Infectious and Inflammatory Disease/Hematology/Musculoskeletal
      • Instrumentation
      • Neurosciences
      • Non-oncology Endocrinology/Neuroendocrine
      • Novel Multimodality & Nonradioactive Probes
      • Novel Radiochemistry & Chelation
      • Oncology
      • Other Solid Tumors
      • Outcomes/Comparative Effectiveness Research & Radiation Safety
      • Pediatrics
      • Preclinical Probes for Neuroimaging
      • Preclinical Probes for Oncology
      • Probes for Cardiovascular, Endocrine and Other - Preclinical
      • Professional Development & Quality Improvement
      • Pulmonary
      • Radiopharmaceutical Sciences
      • Radiopharmacy & Clinical Production
      • Renal/Hypertension
      • Sarcoma/Melanoma
      • Technical Advances & Quantification (this would include image-guided diagnostics/therapy)
      • Thoracic (Lung/Pleura)

Student_Oral

      • Cardiology
      • General Nuclear Medicine
      • PET
      • Radiopharmacy
      • Radiation Safety & Patient Care
      • Theranostics

Student_poster

      • Radiopharmacy

Technologist_oral

      • Cardiovascular Sciences
      • Clinical PET
      • Diagnostic & Therapeutic Nuclear Medicine
      • Instrumentation & Data Analysis
      • Radiopharmaceutical Science, Biology & Dosimetry

Technologist_poster

      • Cardiovascular Sciences
      • Clinical PET
      • Diagnostic & Therapeutic Nuclear Medicine
      • Instrumentation & Data Analysis
      • Neurosciences
      • Radiopharmaceutical Science, Biology & Dosimetry
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 63, Issue supplement 2
August 8, 2022
  • Table of Contents
  • Index by author
Sign up for alerts

Jump to

  • PhysicianPharm_Oral
  • PhysicianPharm_Poster
  • Student_Oral
  • Student_poster
  • Technologist_oral
  • Technologist_poster
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire